To avoid large variation in tumor sizes due to heterogeneity of breast cancer, we selected pairs of tumors (one as a control – injected PBS only, the other treated – injected drug in PBS) that had similar tumor sizes, and performed ultrasound imaging for four weeks to monitor effect of BK channel opener during the growth of tumors. The gene discussed is KCNMA1; the disease is breast carcinoma.